WELL HEALTH TECHS

Research WELL HEALTH TECHS (W7V) on Bullrun: valuation model: 41.1% overvalued, market cap EUR 638.52M, P/E 35.7. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerW7V
• ExchangeF
• CountryCanada
• SectorHealthcare
• IndustryMedical Care Facilities
• CurrencyEUR
• Valuation signal41.1% overvalued
• Market capEUR 638.52M
• P/E35.7
• Financial periodQ4 2025
• RevenueEUR 384.77M
• Net incomeEUR 22.89M
• Free cash flowEUR 37.57M
• Gross margin46.0%

Valuation Snapshot

Bullrun's latest valuation model marks WELL HEALTH TECHS as 41.1% overvalued; latest market cap is EUR 638.52M; P/E is 35.7.

About WELL HEALTH TECHS

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women's health, primary care, and behavioural health. It also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners.

Frequently asked questions

Is WELL HEALTH TECHS overvalued or undervalued?

Bullrun's valuation model currently marks WELL HEALTH TECHS as 41.1% overvalued.

What is WELL HEALTH TECHS's market cap?

WELL HEALTH TECHS's market capitalization is EUR 638.52M.

What is WELL HEALTH TECHS's P/E ratio?

WELL HEALTH TECHS's price-to-earnings (P/E) ratio is 35.7.

What does WELL HEALTH TECHS do?

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally.